Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
384.40
+7.70 (2.04%)
Feb 20, 2025, 5:24 PM IDT

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of 78.38 million as of February 21, 2025. Its market cap has decreased by -55.24% in one year.

Market Cap
78.38M
Enterprise Value
-6.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
384.40

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 78.38M, a decrease of -78.70%. That is a compound annual growth rate of -23.01%.

History

DateMarket Cap% Change
Feb 21, 202578.38M-16.36%
Dec 31, 202493.71M-48.18%
Dec 29, 2023180.84M-29.06%
Dec 30, 2022254.92M-28.46%
Dec 31, 2021356.33M-8.65%
Dec 31, 2020390.07M30.23%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 69.16B
Danel (Adir Yeoshua) 2.53B
Kamada 1.57B
Bait Bakfar 1.09B
Novolog (Pharm-Up 1966) 907.03M
Ilex Medical 800.59M
BrainsWay 762.81M
SofWave Medical 597.96M
Market Cap Rankings